CFGS
HZNP

Concourse Financial Group Securities’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Concourse Financial Group Securities’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-778
Closed -$90K – 2415
2023
Q3 		$90K Sell
778
-87
-10% -$9.35K 0.01% 887
2023
Q2 		$89K Sell
865
-18
-2% -$1.9K 0.01% 898
2023
Q1 		$96.4K Sell
883
-680
-44% -$75.2K 0.01% 882
2022
Q4 		$178K Buy
+1,563
New +$130K 0.01% 641
2022
Q3 		– Sell
-2,153
Closed -$150K – 2358
2022
Q2 		$172K Buy
2,153
+266
+14% +$25.2K 0.01% 633
2022
Q1 		$199K Sell
1,887
-337
-15% -$32.8K 0.01% 638
2021
Q4 		$240K Buy
2,224
+132
+6% +$14.4K 0.01% 667
2021
Q3 		$229K Buy
2,092
+52
+3% +$5.4K 0.01% 678
2021
Q2 		$191K Sell
2,040
-380
-16% -$35K 0.01% 733
2021
Q1 		$223K Buy
2,420
+91
+4% +$7.68K 0.02% 650
2020
Q4 		$170K Buy
2,329
+776
+50% +$57.7K 0.01% 683
2020
Q3 		$121K Buy
1,553
+1,205
+346% +$82.9K 0.01% 718
2020
Q2 		$19K Buy
348
+12
+4% +$513 ﹤0.01% 1321
2020
Q1 		$10K Buy
336
+113
+51% +$3.82K ﹤0.01% 1470
2019
Q4 		$8K Buy
223
+113
+103% +$3.46K ﹤0.01% 1521
2019
Q3 		$3K Sell
110
-125
-53% -$3.23K ﹤0.01% 1499
2019
Q2 		$6K Hold
235
– – ﹤0.01% 1706
2019
Q1 		$6K Sell
235
-147
-38% -$3.48K ﹤0.01% 1712
2018
Q4 		$7K Buy
382
+19
+5% +$372 ﹤0.01% 1563
2018
Q3 		$7K Buy
+363
New +$6.9K ﹤0.01% 1310

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Concourse Financial Group Securities's HZNP Position: Q4 2023 in Review

Concourse Financial Group Securities sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 778 shares — an estimated $90K sold.

Concourse Financial Group Securities first reported a position in HZNP in Q3 2018 and held it in 20 quarters. The position peaked at $240K in Q4 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Concourse Financial Group Securities reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Concourse Financial Group Securities sold 778 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $90K.
  • Concourse Financial Group Securities first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2018 and held it in 20 quarters.
  • Concourse Financial Group Securities's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $240K in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Concourse Financial Group Securities's 13F filing for Q4 2023, filed 7 Feb 2024.